金吾财讯 | 再鼎医药(ZLAB)盘前涨超2%，截至发稿，报25.8美元。消息面上，根据香港联交所11月19日披露的文件，威灵顿投资管理(Wellington Management Group LLP)于11月15日以每股均价27.803美元增持再鼎医药1,012.5万股H股股份，价值约2.82亿美元。增持后，威灵顿投资管理最新持股数目为1.01亿股股份，持仓比例由9.14%升至10.15%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.